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New Zealand Black (NZB) mice spontaneously produce a variety of autoanti- 
bodies, including those to nucleic acids, T  ceils, and erythrocytes (1, 2), and show 
a high serum level of IgM that is probably due to the spontaneously occurring 
polyclonal activation of B cells (3,  4). They also develop immune complex-type 
glomerulonephritis resembling human lupus nephritis (1). Additional abnormal- 
ities found in NZB mice are the productions of a large amount of gp70, a major 
constituent of C-type retroviral  envelope  glycoprotein, and  the  antibodies  to 
gp70,  resulting in  the  formation of gp70  immune complexes (gp70  ICs)  (5). 
These gp70  ICs, as well as DNA-anti-DNA ICs (6), have been implicated in the 
pathogenesis of renal  disease  in  NZB  and  their  progeny  (5,  7-9).  All  these 
immunological abnormalities are  under the control of multiple genes of NZB 
mice, and a specific genetic mechanism regulates the expression of each of the 
various traits (10). 
As compared with this NZB strain, (NZB ×  NZW)F1 (B/W F1) hybrids show 
an earlier onset and a higher incidence of proteinuria associated with increased 
serum levels ofanti-DNA antibodies, gp70 ICs and IgG (1,9, 11). These findings 
can be explained by the involvement of a  New  Zealand White (NZW) gene(s) 
that acts to intensify the expression of relevant autoimmune NZB gene(s) in B/ 
W  F1  hybrids. Either one or two dominant NZW gene(s) have been implicated 
in the increased incidence and severity of the renal disease observed in B/W F1 
hybrids (9,  12). Maruyama et al. (9) suggested that a single dominant NZW gene 
acts to intensify the production of anti-gp70 antibodies, which in turn results in 
the formation of a greater amount of gp70 ICs in B/W F1  hybrids. Our recent 
studies showed that increments in the serum level of anti-dsDNA antibodies in 
the F1  hybrids can be attributed to the combined effect of two independently 
segregating dominant NZW genes. 1 All these genetic studies in B/W F1  ×  NZB 
backcrosses revealed that each one of these three traits, the increased severity of 
renal disease and the enhanced productions of gp70 ICs and anti-DNA antibod- 
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ies, is significantly associated with the inheritance of H-2  ~ haplotype. 
To  investigate  the  possible  effect of  H-2  complex  of  NZW  strain  on  the 
production of autoantibodies and the renal disease observed in  B/W  F 1 mice, 
we  developed  the  ZWD/8  strain,  a  NZW  congenic  line  carrying  the  H-2  a 
haplotype, produced (NZB ×  ZWD/8)F1  (B/WD8 F1) mice, and examined the 
difference in  several immunological abnormalities between the  H-2d/H-2  z het- 
erozygous B/W  F1 and the H-2d/H-2  a homozygous B/WD8  F1  mice. 
Materials and Methods 
Mice and Sera.  ZWD/8 mice, a NZW congenic line carrying the H-2  d haplotype, were 
developed by backcrossing B/W F1 mice to NZW for eight generations. The H-2  a typing 
in each generation was done by a cytotoxicity test against peripheral blood lymphocytes 
using the anti-H-2  d antiserum  produced by immunizing NZW with the spleen ceils of 
NZB mice. Only female mice were used in this study. 
Anti-DNA Antibodies.  Measurement of antibodies to dsDNA and ssDNA was performed 
by the Farr assay with slight modification, as described previously (11). The immunoglob- 
ulin classes  of anti-dsDNA  antibodies were determined by Crithidia luciliae kinetoplast 
immunofluorescence (KIF)  test  (13).  The  specificity of the  KIF  test  for anti-dsDNA 
antibodies was confirmed by staining of the C. luciliae with mouse monoclonal antibodies 
to DNA (14). The mouse sera that showed a positive KIF at 1:10 dilution or more were 
regarded as positive. 
Serum gp70 ICs.  Serum gp70 ICs were measured by the inhibition radioimmunoassay, 
as described elsewhere (9). 
Natural Thvmocytotoxic Autoantibody (NTA).  NTA was measured by a two-step cytotox- 
icity test against BALB/c thymocytes, as described previously (2). The sera that showed 
50% or more cytotoxicity at 1:2 dilution were regarded as positive in this study. 
Anti-erythrocyte Autoantibody (AEA).  AEA was examined by direct Coombs' test. 
Serum IgG and lgM Levels.  Solid phase inhibition radioimmunoassay was performed to 
determine the serum levels of IgG and IgM. A mixture of ~SI-labeled myeloma proteins, 
MOPC 21  (71, K), RPC 5 (y.,,, K) and MOPC  195 (Y2b, x), were used for IgG assay and 
125I-labeled MOPC 104E (#,)~) for IgM assay. 
Proteinuria.  The onset of renal disease was monitored by biweekly measurement of 
proteinuria (12). The proteinuria of 111 mg/100 ml or more was regarded as positive. 
Statistical Analysis.  Statistical analysis  was performed using X  2 Yates test and Student's 
t-test. Probability values (P values) of <5% were considered as significant. 
Results 
As in the case of NZW, the ZWD/8  strain, a NZW congenic line carrying the 
H-2  d haplotype, shows no immunological abnormalities.  We compared the im- 
munological abnormalities between the H-2d/H-2  z B/W  F1  and the H-2a/H-2  a 
B/WD8  F1  mice. 
Anti-DNA Antibodies.  As shown in Fig.  1 A and B, the B/WD8 F 1 mice showed 
markedly lower serum  levels of dsDNA- and ssDNA-binding activities as meas- 
ured by the Farr assay than did the B/W  F1  mice at 7  months (t =  3.253, P  < 
0.01  for dsDNA and t =  4.450, P  <  0.001  for ssDNA) and 9 months of age (t = 
4.232, P  <  0.001  for dsDNA and t =  3.738, P <  0.001  for ssDNA). Fig. 2 shows 
the data  of the  KIF test,  indicating that  as compared  with  B/W  F1  mice,  B/ 
WD8  F1  mice showed a  significantly lower incidence of IgG anti-dsDNA  anti- 
bodies (X 2 =  15.631, P  <  0.001).  A  lack of significant difference, however, was 
observed  in  the  incidences  of IgM  anti-dsDNA  antibodies  between  these  two 
hybrid strains of mice (X 2  =  2.011, P  >  0.10). 230  HIROSE  ET  AL.  BRIEF  DEFINITIVE  REPORT 
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FIGURE  l.  Comparisons  of (A) dsDNA-binding  activities,  (B)  ssDNA-binding  activities,  (C) 
the amounts of serum gp70 ICs, (D) serum  IgG levels, and (E) serum lgM levels between  B/ 
W  F1  (71) and B/WD8  F1  (D) mice at 4, 7, and 9  months of age. Each vertical column shows 
the  mean  value  and  bars  represent  the  SE.  The  number  of  mice  tested  is  shown  in  the 
parenthesis. P  values are estimated by Student's t-test at each month. 
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FIGURE 2.  (A) IgG anti-dsDNA antibodies and (B) IgM anti-dsDNA antibodies measured by 
the KIF test in B/W F1 and B/WD8  F1  mice at 7 months of age. KIF titer is expressed as the 
reciprocals of the highest serum dilution giving positive kinetoplast immunofluorescence. 
Serum gp70 ICs.  Fig.  1 C shows that the average  amounts of serum  gp70  ICs 
in  B/WD8  F1  mice  were  significantly  lower than  in B/W  F1  mice at  7  months 
(t =  3.470, P  <  0.01) and 9  months of age (t =  2.627, P  <  0.02). 
NTA a~M AEA.  As shown in Table I, there was a lack of significant difference 
in  both  the percentage  of cytotoxicity and  the incidence  of NTA,  as well  as in 
the prevalence of AEA between  B/W  FI  and B/WD8  FI  mice. 
Serum  Immum)globuli~s.  The  serum  levels  of  IgG  were  estimated  by  the 
amounts of IgG~  and IgG9.  At 4  months of age,  B/W  F1  mice showed a  higher 
mean  serum  level  of  IgG  than  did  B/WD8  F1  mice  (t  =  2.495,  P  <  0.02). 
However,  B/WD8  F1  mice showed as high a serum  level of IgG as did B/W  FI 
mice at 7 and 9  months of age (Fig.  1 D). There was no significant difference  in 
the mean serum  levels of IgM  between  these two hybrid mice (Fig.  1E). HIROSE  ET  AL.  BRIEF  DEFINITIVE  REPORT  231 
TABLE  I 
Appearances of Natural Thymocytotoxic  Autoantibody and Anti-erythrocyte  Autoantibody in B/W 
F1 and B/WD8 F1 Mice 
NTA  AEA 
Mouse  No. positive/No.  No. positive/No. 
Age  % Cytotoxicity  tested (%)  Age  tested (%) 
??~0  ~0 
B/W F1  7  67.1 ± 14.8%*  22/24 (92)  9  3/12 (25) 
B/WD8 F1  7  63.4 ±  10.3%  22/24 (92)  9  4/19 (21) 
* The mean value of percent cytotoxicity ±  1 SD to BALB/c thymocytes at 1:2 serum dilution. 
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FIGURE 3.  Comparisons of the cumulative incidences of proteinuria and mortality between 
17  B/W F1  and 34  B/WD8 F1  mice. 0, proteinuria in B/W F1; O, proteinuria in B/WD8 
F1; &, mortality in B/W F1; A, mortality in B/WD8 F1  mice. 
Protei~mria and Mortalih,.  Fig. 3 shows that in B/W F1  mice, proteinuria first 
appeared at 5 months of age, and the cumulative incidence reached 76% by 10 
months of age. The cumulative mortality of B/W F1  mice had reached 59% by 
the same time. In B/WD8 F1  mice, proteinuria  first appeared at 6 months and 
this incidence reached only 9% by 10 months of age. The cumulative mortality 
remained in only 3% at the same time. 
Discussion 
Our findings provide good evidence that the H-2-1inked NZW gene(s) acts to 
intensify the expression of NZB autoimmune disease genes in B/W F1  hybrids. 
This NZW gene action was related to the traits, anti-DNA antibodies, circulating 
retroviral gp70 ICs and the IC-type glomerulonephritis,  but not to NTA, AEA, 
and the serum levels of IgG and IgM. 
The  NZB strain  contributes a  single  dominant  locus (Lpn-1) or a  cluster  of 
closely linked loci to the development of renal disease and either one (Lpn-2) or 
a  combined  effect of two dominant  loci  (Lpn-2, Lpn-3)  of the  NZW  strain  is 
involved in  the accelerated onset and  the increased  severity of renal disease in 
B/W F1  hybrids (9,  12). Related to this may be the findings that a major single 
dominant  locus of NZB strain  (Agp-l) determines the  production  of anti-gp70 
antibodies and  that  the  magnitude  is to a  great degree  intensified  by a  single 
dominant locus of NZW strain (Agp-3) (9).  The spontaneous production of anti- 232  HIROSE  ET  AL.  BRIEF  DEFINITIVE  REPORT 
dsDNA antibodies in  the B/W  F1  hybrids is determined by a  combined effect 
of two dominant  NZB  loci (Ads-l, Ads-2) (11),  and  a  combined effect of two 
dominant loci of NZW strain (Ads-3, Ads-4) acts to increase the amount of anti- 
dsDNA antibody production and to convert the class of the antibodies from IgM 
to IgG. 1 All these studies suggested that Lpn-1, Agp-1, and Ads-1 loci are to some 
extent linked to H-2 complex of NZB and that Lpn-2, Agp-3, and Ads-3 loci are 
linked  to  H-2  complex  of NZW  strain  (9-12).  The  present  studies  presented 
good evidence that among these, Lpn-2, Agp-3, and Ads-3 loci are located within 
or closely linked  to the  H-2 complex of NZW mice.  Development of the  H-2 
congenic ZWD/8  line  raises  another  important  point.  The  H-2  a haplotype of 
ZWD/8 line was derived from the NZB strain,  nevertheless, ZWD/8 developed 
no immunological  abnormalities.  Therefore,  we concluded that  neither Lpn-1 
nor Agp-1 is located within  the  H-2 complex of the  NZB strain.  Close linkages 
among Ads-l, Agp-1, and Lpn-1 on chromosome 17 of NZB strain (10) suggested 
that Ads-1 is also outside of the H-2 complex. 
One of the possible pathways by which the  H-2Z-linked NZW gene promotes 
the autoimmunity  in  B/W  F1  mice is through  the role of I  region  in  the  H-2 
complex. The findings of Papoian and Talal (15), that the response of B/W F 1 
mice to DNA occurs primarily  through  the  NZW H-27 hapiotype of their  own 
antigen-presenting cells, may be relevant. 
Finally, it is noteworthy that the H-2Z-linked NZW gene(s) may be involved in 
the class conversion of anti-dsDNA antibodies from IgM to IgG.  In contrast to 
the  NZB  mice  in  which  the  IgM  is  the  predominant  class  of  anti-dsDNA 
antibodies, the IgG class antibodies predominate in B/W F1  hybrids.1 However, 
this gene action of NZW mice was proved to be unrelated to the increased serum 
revel of polyclonal IgG that also characterized the B/W F1  hybrids. 
Summary 
To investigate the possible enhancing effect of the H-2  z haplotype of the New 
Zealand  White  (NZW)  strain  on  the  production  of autoantibodies  and  renal 
disease observed in  B/W  F1  mice,  we developed the  ZWD/8  strain,  a  NZW 
congenic line carrying  the  H-2  a haplotype,  produced (NZB ×  ZWD/8)F1  (B/ 
WD8 F1) mice, and  examined  the  difference in  several immunological  abnor- 
malities  between  the  B/W  F1  (H-2d/H-27)  and  the  B/WD8  F1  (H-2d/H-2  a) 
mice. In comparison with B/W F1  mice, the B/WD8 F1 mice showed markedly 
lower serum  levels of the  anti-DNA  antibodies and  the  gp70  ICs, and  a  later 
onset and a  lower incidence of proteinuria  with a  lower mortality.  In contrast, 
there was no significant  difference in  the incidences and  the amounts of both 
natural thymocytotoxic autoantibody and anti-erythrocyte autoantibody between 
these two hybrid strains.  Further,  the serum levels of IgG and IgM in B/WD8 
F1  mice were as high as those in B/W F1  mice. These findings indicate that the 
gene(s)  that  is  within  or  closely  linked  to  the  H-2  complex  of  NZW  strain 
specifically acts to intensify the levels of anti-DNA antibodies and gp70 ICs, and 
to promote the severity of renal disease in B/W F1  mice. This gene may play a 
role in the class conversion of anti-dsDNA antibodies from IgM to IgG. HIROSE  ET  AL.  BRIEF  DEFINITIVE REPORT  233 
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